Legal Representation
Attorney
Alan Kamrath
USPTO Deadlines
Next Deadline
1925 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-12)
Due Date
November 12, 2030
Grace Period Ends
May 12, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 12, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 12, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 9, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 9, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 19, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 19, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 18, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 18, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 23, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 23, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 3, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 3, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 9, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 9, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 9, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 7, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 7, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 31, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 12, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 10, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Albumin dietary supplements; Albuminous foodstuffs for medical purposes for medical purposes in the nature of albumin dietary supplements; Albuminous preparations for medical purposes; Casein dietary supplements; Diastase for medical purposes; Dietary supplements with a cosmetic effect; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical use; Enzyme dietary supplements; Food for babies; Freeze-dried food adapted for medical purposes; Glucose dietary supplements; Herbal teas for medicinal purposes; Herbal extracts for medical purposes; Linseed dietary supplements; Linseed oil dietary supplements; Nutritional supplements; Plant extracts for pharmaceutical purposes; Propolis dietary supplements; Protein dietary supplements; Vitamin preparations; Yeast dietary supplements; Nutraceuticals for use as a dietary supplement; Powdered nutritional supplement drink mix; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, egg; Nutritionally fortified beverages for medical purposes; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary fiber to aid digestion; Dietary fiber for treating constipation
First Use Anywhere:
Jun 1, 2023
First Use in Commerce:
Jan 30, 2024
Additional Information
Design Mark
The mark consists of "MD FORMULA," where the letter "m" is shows as a horizontal helix. The term is below three Chinese characters with a cross design above that uses a helix as the vertical line.
Color Claim
Color is not claimed as a feature of the mark.
Other
The non-Latin characters in the mark transliterate to "Yi," Zi" and "Fang" and this means "to treat," "of" and "square" in English. Taken as a phrase, the terms mean "medical formula."
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MD FORMULA" or the non-Latin characters that transliterate to "MEDICAL FORMULA"